Both CCNE2 and CDK2 expression remained high and unchanged after doxorubicin treatment, and it has been described that overexpression and interaction of these two genes is related with tamoxifen-resistance mechanisms in breast cancer29. Here, CCNE2 is linked to neoplasm.